Medical Equipment

Global Immunodiagnostics Market Valuation and Growth Prospects: $32.89 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the immunodiagnostics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Immunodiagnostics Market Size?

The immunodiagnostics market has experienced substantial growth in recent years. Its valuation is projected to increase from $22.88 billion in 2024 to $24.32 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.3%. The expansion observed during prior periods is attributable to factors such as the escalating prevalence of infectious diseases, an uptick in autoimmune conditions, advances in cancer diagnosis and monitoring, the global nature of infectious diseases, ongoing public health initiatives, and widespread screening programs.

The immunodiagnostics market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $32.89 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.8%. Several factors are contributing to this growth during the forecast period, including pandemic preparedness and response, personalized medicine and biomarker discovery, expanding healthcare infrastructure in emerging markets, integration with laboratory information systems, and the increasing burden of chronic diseases. Key trends expected during the forecast period encompass multiplexing technologies, point-of-care testing (POCT), biomarker discovery and personalized medicine, the emergence of digital immunodiagnostics, and a shift toward liquid biopsy.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

What Core Market Drivers Are Expanding The Immunodiagnostics Industry?

The rising incidence of infectious diseases is anticipated to fuel the expansion of the immunodiagnostics market in the future. Infectious diseases are defined as illnesses transmissible between individuals, caused by pathogens such as viruses, bacteria, fungi, or parasites. An immunodiagnostic assay is utilized to detect a virus present in a blood sample. For example, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, indicated that tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing an upsurge of 1,295 cases. This growing prevalence of infectious diseases is thus projected to drive the immunodiagnostics market.

What Segment Insights Are Highlighted In The Immunodiagnostics Market Report?

The immunodiagnosticsmarket covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments, Software And Services

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, ELISA Readers

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

Which Notable Trends Are Transforming The Immunodiagnostics Market Outlook?

Key companies within the immunodiagnostics market are dedicated to creating innovative solutions, including the S. pneumoniae antigen immunodiagnostic assay, to support the diagnosis of pneumococcal pneumonia infection. The S. pneumoniae Antigen Immunodiagnostic Assay serves as a test to identify the presence of Streptococcus pneumoniae antigens in bodily fluids, thereby assisting in the diagnosis of pneumococcal infections. For instance, in September 2024, DiaSorin S.p.A., an Italy-based biotechnology company, launched its LIAISON S. pneumoniae antigen immunodiagnostic assay. The LIAISON S. pneumoniae Antigen Immunodiagnostic Assay is a diagnostic test specifically designed for the qualitative detection of Streptococcus pneumoniae antigens in urine samples from adults suspected of pneumococcal pneumonia. This assay offers a high-throughput solution, empowering healthcare providers to quickly diagnose and distinguish pneumococcal pneumonia from other respiratory infections. Operating on LIAISON CLIA analyzers, the test yields results in just 35 minutes, which in turn facilitates prompt and targeted antimicrobial therapy. Moreover, its capacity to identify 91 serotypes enhances clinical decision-making and supports effective antibiotic stewardship, marking a significant innovation in the immunodiagnostics field for community-acquired pneumonia.

Which Firms Are Driving Innovation Within The Immunodiagnostics Market?

Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

What Regional Trends Are Shaping Growth In The Immunodiagnostics Market?

North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp

Browse Through More Reports Similar to the Global Immunodiagnostics Market 2025, By The Business Research Company

Orphan Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795